Neoleukin Therapeutics Inc (NLTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NLTX | AMGN | VRTX | REGN | GILD |
| Company | Neoleukin Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 13.80 | 333.23 | 497.00 | 1,075.35 | 72.89 |
| High | 14.36 | 336.35 | 498.77 | 1,078.71 | 73.32 |
| Low | 13.68 | 332.47 | 491.52 | 1,064.95 | 72.02 |
| Last | 13.96 | 336.36 | 495.38 | 1,071.02 | 72.56 |
| Change | +0.20 | +5.07 | +3.81 | +7.42 | -0.22 |
| % Change | +1.45% | +1.53% | +0.78% | +0.70% | -0.30% |
| Volume | 28,275 | 891,235 | 580,237 | 131,808 | 2,139,799 |
| 20-Day Average Volume | 33,865 | 2,042,339 | 1,117,381 | 417,153 | 6,329,358 |
| Previous Close | 13.76 | 331.29 | 491.57 | 1,063.60 | 72.56 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.45 | 321.00 | 481.84 | 1,064.44 | 69.78 |
| 20-Day Raw Stochastic | 62.00% | 89.20% | 87.16% | 63.09% | 70.93% |
| 20-Day Relative Strength | 50.56% | 68.26% | 67.03% | 58.19% | 62.34% |
| Weighted Alpha | +35.60 | +41.77 | +43.78 | +42.62 | -4.95 |
| Today's Opinion | 72% Sell | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Previous Opinion | 96% Sell | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Last Month's Opinion | 88% Sell | 100% Buy | 100% Buy | 100% Buy | 64% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.29% since 12/11/23 | +1.60% since 07/15/24 | +0.76% since 07/15/24 | -1.00% since 07/15/24 | +2.15% since 07/15/24 |
| Low | 3.25 on 12/12/23 | 328.00 on 07/16/24 | 478.78 on 07/17/24 | 1,060.74 on 07/19/24 | 70.33 on 07/16/24 |
| High | 3.64 on 12/15/23 | 338.98 on 07/18/24 | 498.77 on 07/22/24 | 1,100.08 on 07/16/24 | 74.92 on 07/18/24 |
| 1-Month | |||||
| %Chg | +4.18% since 11/17/23 | +8.85% since 06/21/24 | +5.52% since 06/21/24 | +1.72% since 06/21/24 | +2.35% since 06/21/24 |
| Low | 3.18 on 11/22/23 | 306.11 on 07/03/24 | 466.01 on 07/03/24 | 1,011.67 on 07/03/24 | 66.01 on 07/05/24 |
| High | 3.68 on 11/30/23 | 338.98 on 07/18/24 | 498.77 on 07/22/24 | 1,106.16 on 07/12/24 | 74.92 on 07/18/24 |
| 3-Month | |||||
| %Chg | -9.35% since 09/18/23 | +23.36% since 04/22/24 | +23.67% since 04/22/24 | +19.01% since 04/22/24 | +8.04% since 04/22/24 |
| Low | 3.18 on 11/22/23 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 4.14 on 10/10/23 | 338.98 on 07/18/24 | 498.77 on 07/22/24 | 1,106.16 on 07/12/24 | 74.92 on 07/18/24 |
| 6-Month | |||||
| %Chg | -9.84% since 06/16/23 | +8.15% since 01/22/24 | +12.37% since 01/22/24 | +13.62% since 01/22/24 | -7.78% since 01/22/24 |
| Low | 3.05 on 08/14/23 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 4.70 on 07/17/23 | 338.98 on 07/18/24 | 498.77 on 07/22/24 | 1,106.16 on 07/12/24 | 81.06 on 01/25/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 32,799 | 177,715,552 | 126,851,120 | 117,193,824 | 90,399,088 |
| Shares Outstanding, K | 9,398 | 536,435 | 258,053 | 110,186 | 1,245,853 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | -57,560,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 6,686,000,000 |
| Last Quarter Net Income | -4,530,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -4,170,000,000 |
| 60-Month Beta | 1.11 | 0.58 | 0.39 | 0.13 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.41 on 11/14/23 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 11/13/23 | 08/06/24 | 08/01/24 | 08/01/24 | 08/08/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.770 on 06/14/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.77 | 32.41 | 28.76 | 18.24 |